- Home
- LOOP vs CRVO Comparison
LOOP vs CRVO Comparison
Compare LOOP & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOOP
- CRVO
- Stock Information
- Founded
- LOOP 2010
- CRVO 2001
- Country
- LOOP Canada
- CRVO United States
- Employees
- LOOP N/A
- CRVO N/A
- Industry
- LOOP Major Chemicals
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- LOOP Industrials
- CRVO Health Care
- Exchange
- LOOP Nasdaq
- CRVO Nasdaq
- Market Cap
- LOOP 82.6M
- CRVO 67.4M
- IPO Year
- LOOP N/A
- CRVO N/A
- Fundamental
- Price
- LOOP $1.65
- CRVO $6.85
- Analyst Decision
- LOOP
- CRVO Strong Buy
- Analyst Count
- LOOP 0
- CRVO 8
- Target Price
- LOOP N/A
- CRVO $25.57
- AVG Volume (30 Days)
- LOOP 367.9K
- CRVO 111.1K
- Earning Date
- LOOP 07-14-2025
- CRVO 08-08-2025
- Dividend Yield
- LOOP N/A
- CRVO N/A
- EPS Growth
- LOOP N/A
- CRVO N/A
- EPS
- LOOP N/A
- CRVO N/A
- Revenue
- LOOP $10,889,000.00
- CRVO $9,308,215.00
- Revenue This Year
- LOOP N/A
- CRVO N/A
- Revenue Next Year
- LOOP $592.45
- CRVO N/A
- P/E Ratio
- LOOP N/A
- CRVO N/A
- Revenue Growth
- LOOP 7016.99
- CRVO 15.14
- 52 Week Low
- LOOP $0.85
- CRVO $1.80
- 52 Week High
- LOOP $2.34
- CRVO $22.57
- Technical
- Relative Strength Index (RSI)
- LOOP 64.11
- CRVO 36.51
- Support Level
- LOOP $1.55
- CRVO $6.80
- Resistance Level
- LOOP $1.67
- CRVO $8.30
- Average True Range (ATR)
- LOOP 0.20
- CRVO 0.57
- MACD
- LOOP 0.00
- CRVO -0.05
- Stochastic Oscillator
- LOOP 38.94
- CRVO 6.17
About LOOP Loop Industries Inc.
Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.